Novartis AG Cardiovascular Update Call Transcript
Good morning and good afternoon, and welcome to the Novartis cardiovascular update. (Operator Instructions) And the conference is being recorded today. (Operator Instructions) A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. (Operator Instructions)
With that, I would like to hand over to Mr. Samir Shah, Head of Investor Relations. Please go ahead, sir.
Thank you very much, and good morning and good afternoon to everybody. A big, big thank you for joining us this afternoon in European time for the Novartis Cardiovascular Update. With us today, we have quite a lot of speakers, but hopefully, we'll leave enough time after the presentation for the questions and answers.
We have Dave Soergel, who's the Global Head of Cardiovascular, Renal and Metabolism Development; Rod Wooten, who is the Global Head of Marketing, Novartis Pharmaceutical; Victor Bulto, who's Head of Novartis Pharmaceuticals U.S.; and our external speaker is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |